| Literature DB >> 35536402 |
Marco Merlo1, Giulia Gagno2, Anna Baritussio3, Barbara Bauce3, Elena Biagini4, Marco Canepa5,6, Alberto Cipriani3, Silvia Castelletti7, Santo Dellegrottaglie8, Andrea Igoren Guaricci9, Massimo Imazio10, Giuseppe Limongelli11, Maria Beatrice Musumeci12, Vanda Parisi4, Silvia Pica13, Gianluca Pontone14, Giancarlo Todiere15, Camilla Torlasco7, Cristina Basso3, Gianfranco Sinagra2, Pasquale Perrone Filardi16, Ciro Indolfi17, Camillo Autore12, Andrea Barison15.
Abstract
Cardiac magnetic resonance (CMR) has become an essential tool for the evaluation of patients affected or at risk of developing cardiomyopathies (CMPs). In fact, CMR not only provides precise data on cardiac volumes, wall thickness, mass and systolic function but it also a non-invasive characterization of myocardial tissue, thus helping the early diagnosis and the precise phenotyping of the different CMPs, which is essential for early and individualized treatment of patients. Furthermore, several CMR characteristics, such as the presence of extensive LGE or abnormal mapping values, are emerging as prognostic markers, therefore helping to define patients' risk. Lastly new experimental CMR techniques are under investigation and might contribute to widen our knowledge in the field of CMPs. In this perspective, CMR appears an essential tool to be systematically applied in the diagnostic and prognostic work-up of CMPs in clinical practice. This review provides a deep overview of clinical applicability of standard and emerging CMR techniques in the management of CMPs.Entities:
Keywords: Cardiac magnetic resonance; Cardiomyopathies; Diagnosis; Prognosis
Year: 2022 PMID: 35536402 DOI: 10.1007/s10741-022-10235-9
Source DB: PubMed Journal: Heart Fail Rev ISSN: 1382-4147 Impact factor: 4.654